1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Spirig Pharma Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients MD-3511356, Standard Sun Protection Measures - Actinic Keratoses, Squamous Cell Carcinomas | Phase 3 | Terminated | Spirig Pharma Ltd. | 244 | 2010-11-01 | 2016-01-08 |
Carcinoma, Squamous Cell (1) · Keratosis, Actinic (1)
Austria (1) · Czechia (1) · France (1) · Germany (1) · Ireland (1) · Netherlands (1) · Switzerland (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Claas Ulrich, MD (1)